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THE MOTIVATIONAL EFFECTS OF 3,4-METHYLENDIOXYMETHAMPHETAMINE
ON RESPONDING MAINTAINED BY A PROGRESSIVE-RATIO SCHEDULE
OF WATER DELIVERY
Sean P. Laraway, M.A.
Western Michigan University, 2002
Relative to their reinforcing and discriminative functions, the establishing
operation (EO) function of drugs has received little attention from behavioral
pharmacologists. This study investigated in rats the EO function of
3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) using a progressive-ratio
(PR) 2 schedule of water delivery. Relative to vehicle control levels, Lower doses
(1.0 and 1.8 mg/kg ip) had no effects, whereas the higher doses (3.2, 5.6 mg/kg ip)
significantly decreased breaking points. Changes in the level of water deprivation
significantly changed breaking points. In contrast to previous research, this study
found no evidence that MDMA functioned as an EO for water. These results, along
with findings from other studies using PR schedules, emphasize the need for caution
when interpreting drug-induced changes in breaking points.
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INTRODUCTION
Identification of behavioral mechanisms of drug action remains a primary goal of
behavioral pharmacology (Poling, 2000; Thompson & Schuster, 1968).

Such

behavioral mechanisms include a drug's operant and respondent functions and its
capacity to modulate the behavioral control of other events.

When investigating

behavioral mechanisms of drug action, researchers have concentrated primarily on
drugs' reinforcing and discriminative stimulus functions. Although these functions
are important for understanding drug effects, drugs can affect behavior in other
ways, such as by altering the reinforcing or punishing effectiveness of behavioral
consequences (e.g., Griffiths, Wurster, & Brady, 1981; Houser, 1978; Laraway,
Snycerski, Byrne, & Poling, 2000; Levine & Billington, 1989; Mello, Mendelson, &
Kuehnle, 1982; Miller,

1956, 1957; Northrup, Fusilier,

Borrero, 1997; Poling, 1986).
variables.

Swanson, Roane, &

That is, drugs may function as motivational

Researchers have not systematically investigated drug effects on the

effectiveness of reinforcers and punishers; the relative paucity of research on these
effects represents a considerable gap in our knowledge.
One conceptual

development that might facilitate

research

into the

motivational effects of drugs is the emergence of an operant approach to motivation,
primarily

from the writings of Michael (1982, 1983, 1988, 1993a, 1993b,

2000). Michael reintroduced, extended, and popularized the establishing operation
(EO) concept, first used by Keller and Schoenfeld (1950), and then by Millenson
(1967), to refer to variables that "established" events as effective consequences.
The EO concept represents an environment-based theory of motivation that is w e 11integrated with other operant concepts. Interestingly, few behavioral
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pharmacologists seem to have been influenced by Michael's work, for they have made
little use of the establishing operation concept, though there are some exceptions (e.g.,
Northrup et al., 1997; Poling, 1986; Poling & Byrne, 2000).
Building on Michael's previous work on the EO concept, Laraway, Snycerski,
Michael, and Poling (2002) extended and refined behavior-analytic motivational
concepts and terminology. These authors termed all variables that have motivational
effects motivative operations (MOs), which they defined as environmental events,
operations, or stimulus conditions that affect behavior by altering

(a) the

effectiveness of reinforcers or punishers (the value-altering effect) and (b) the
characteristics of operant response classes related to those consequences (the

behavior-altering effect). The value-altering effect, as a generic term, subsumes
the following specific effects of MOs: (a) the reinforcer-establishing effect, (b) the
reinforcer-abolishing

effect, (c) the punisher-establishing effect, and (d) the

punisher-abolishing effect.
(2002)

Based on these value-altering effects, Laraway et al.

identified two basic MO subtypes: establishing operations (EOs) and

abolishing operations (AOs), which make consequences more or less effective,
respectively. The behavior-altering effect, as a generic term, subsumes two effects
of MOs: (a) the evocative effect and (b) the abative effect (see Laraway, Snycerski,
Michael, & Poling, in press). The evocative effect represents an increase, and the
abative effect represents a decrease, in a measure of some characteristic of an
operant response (e.g., response rate, resistance to change, breaking points under
progressive-ratio schedules).

As an approach to motivation, the MO concept possesses some desirable
features that should expedite investigations into drug effects and the variables that
modulate those effects.

First, the MO concept provides a consistent taxonomy of
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variables that influence the effectiveness of reinforcers and punishers. Researchers
have long recognized that the effectiveness of consequences fluctuates across time and
settings (Millenson, 1967), and MOs are among the variables that influence these
fluctuations. Second, unlike traditional motivational concepts (e.g., needs, craving),
MOs are measured at the same level of analysis as the behavior of interest and are
described in clear relation to other operant controlling variables.

This tight

integration of the MO concept with other behavioral concepts allows behavioral
pharmacologists to describe the motivational effects of drugs and other events
without relying on unobservable or poorly defined processes or events (Sundberg,
1993 ), such as cravings, which often fail to correlate with the behaviors of interest
(Poling, in press) and which have no clear connection to operant concepts.
Beyond its significance for a general understanding of drug effects, the MO
concept has considerable importance for drug-abuse treatment research, which
frequently involves searching for variables that reduce the reinforcing efficacy of
abused drugs. Many pharmacotherapies for drug abuse function as motivational
variables (a) by reducing the reinforcing effectiveness of abused drugs (e.g.,
methadone therapy for heroin abuse) or (b) by changing the function of the abused
drug from reinforcing to punishing (e.g., disulfiram therapy for alcohol abuse)
(Bigelow, Stitzer, & Liebson, 1986; Hall, Clark, & Sees, 1996; Schuster, 1986).
In terms of the MO concept, pharmacotherapies that operate as in (a) function as AOs
for drug reinforcers, while those that operate as in (b) simultaneously function as
AOs for drugs' reinforcing effects and EOs for their punishing effects. By providing a
consistent description of variables having common behavioral effects, the MO concept
may help guide· research on the neurochemical mechanisms that underlie these
effects, thereby increasing the power and scope of our behavioral interventions for
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drug abuse. ¾. Johanson (1990) noted: "an understanding of the variables affecting
the rein forcing

effects of drugs [i.e., motivative operations] is of paramount

importance in developing effective prevention and treatment interventions" (p.

385).
Drug-:-abuse researchers, healthcare professionals, and government agencies
have demonstrated increasing concern over the growth in the use of the popular
"club

drug"

(±)3,4-methylenedioxymethamphetamine

(MOMA,

ecstasy,

E),

particularly by young people at dance clubs or raves (McDowell & Kleber, 1994;
Schwartz & Miller,

1997).

The apparent growth in MOMA use makes a complete

understanding of the many behavioral effects of this drug critical.
reinforcing and discriminative

In addition to its

functions (Steele, Mccann, & Ricaurte, 1994),

MOMA appears to function as an EO for water in a manner similar to water
deprivation.

For example, Rezvani, Garges, Miller, and Gordon (1992) utilized a

choice procedure to investigate the effects of acute and subchronic injections of
MOMA on ethanol preference in two strains of ethanol-preferring rats [i.e., Fawn

Hooded

(FH) and ethanol-pre ferring (P) rats]. In this study, all rats received free

access to food, water, and a 10% (v/v) ethanol solution in their home cages, and
their daily intake of food, water, and ethanol solution was recorded.

In the first

experiment, rats received a single injection of either saline solution or 5.0 mg/kg
MOMA after ethanol and water intake stabilized.

Results of the first experiment

indicated that for both strains of rats a single injection of 5.0 mg/kg MOMA
significantly

reduced mean ethanol intake and significantly

increased water

consumption, relative to baseline (no injection) and vehicle conditions. Moreover,
in both strains of rats 5.0 mg/kg MOMA significantly reduced the proportion of
ethanol intake to total fluid intake, an index of ethanol preference.
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In a second experiment, Rezvani et al. ( 1992) administered daily injections
of either MDMA or saline for three consecutive days to both strains of rats. All other
aspects of the second experiment were similar to those in the first experiment. In
the second experiment, three-day administration of 5.0 mg/kg MDMA significantly
reduced ethanol intake in FH rats on each day. No significant changes in food or water
consumption were found with this strain.

As was found with the FH rats, the

subchronic administration regimen significantly reduced ethanol intake in the P
rats. In contrast to the FH rats, however, the P rats exhibited a significant increase
in water intake for all three days and a significant decrease in food intake for the
first two days. The changes in food, water, and ethanol consumption due to MDMA
administration seen in this study can be interpreted as reflecting changes in the
reinforcing effectiveness of these stimuli (Higgins, Bickel, & Hughes, 1993).
Hence, in this study MDMA appeared to have functioned as an EO for water and as an
/-0 for food and ethanol, and these functions depended, in part, on genetic variables.
It is not surprising that MDMA abolished the reinforcing effectiveness of food, given
the drug is structurally related to the amphetamines, which typically reduce food
consumption.
Byrne, Baker, and Poling (2000) examined the effects of MDMA on response
acquisition with immediate and delayed water delivery. Byrne et al. found that when
water was delivered under a fixed-ratio (FR) 1 schedule, rats that received MDMA
made more responses and earned more water deliveries than did rats that received
vehicle. To the extent that more robust acquisition provides evidence of increased
reinforcing effectiveness (Millenson,

1967), Byrne et al.'s results suggest that

MDMA engendered better acquisition of lever pressing by altering the reinforcing
effectiveness of water, although this effect depended on the delay to water delivery.
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MOMA could exert its motivational effects through several possible physiological
mechanisms.

In rats, MOMA has been shown to induce hyperthermia, increase

evaporative water loss, and increase salivation (Green, Cross, & Goodwin, 1995;
Gordon, Watkinson, O'Callaghan, & Miller,

1991; Spanos & Yamamoto, 1989).

These physiological effects, alone or in combination, could increase the reinforcing
value of water.
In sum, the results of Rezvani et al. (1992) and Byrne et al. (2000) suggest
that, similar to water deprivation, MOMA may function as an EO for water delivery.
However, as Miller (1956, 1957) noted, the motivational effects of drugs and other
events should be assessed in a variety of ways to prevent misleading generalizations
from results that depend on the specific procedure used to index reinforcing
effectiveness.

Due to the importance of characterizing MDMA's effects and the

relative paucity of research on drug MOs, the present study examined further the
possible motivational (i.e., EO) function of MOMA for water using a well-accepted .
assay of reinforcing effectiveness, the progressive-ratio (PR) schedule. To our
knowledge, no studies have examined the effects of MOMA on responding reinforced
by water delivery arranged under a PR schedule.
Progressive-ratio schedules require subjects to execute a systematically
increasing number of responses for each successive reinforcer (Hodos, 1961). For
example, under a PR 2 schedule of water delivery, the number of responses the
subject must emit in the session begins at two and is incremented by two responses
each time the subject earns a water delivery. Thus, under a PR 2 the first 10 ratios
in a given experimental session would be 2, 4, 6, 8, 10, 12, 14, 16, 18, and 20.
The response requirement continues to increase until the subject ceases to respond
for some specified period, usually between 5 and 15 minutes, at which time the
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session terminates (e.g., Hodos, 1961; Hodos & Kalman, 1963; Thomas, 1976). The
number of responses in the last completed ratio of the session, termed the breaking

point, serves as the primary measure of reinforcing value under the PR schedule
(Hodos, 1961; Stewart, 1975). The breaking point reflects the threshold at which
the organism wil_l

no longer work on the schedule given the current response

requirements or, alternatively, the point at which the scheduled consequence fails to
maintain performance. Progressive-ratio schedules appear to provide a quantitative
index of reinforcing effectiveness, with effective reinforcers defined as those that
maintain relatively high breaking points (Hodos & Kalman, 1963; Lattal, 1991). If
MDMA increases the reinforcing effectiveness of water, and if PR schedules assess
reinforcing effectiveness, as is commonly asserted (e.g., Hodos, 1961; Hodos &
Kalman, 1963; Katz, 1990; Stafford, LeSage, & Glowa, 1998), breaking points
under a PR schedule should increase when MDMA is administered to rats.
METHOD

Subjects
Five experimentally naive male Sprague-Dawley rats (C harles River,
Portage, Ml), approximately 50 days old at the beginning of the study, served as
subjects. Rats were housed individually in plastic cages (24 cm long x 31.5 cm wide
x 21 cm high) located in a colony room maintained on a 12-hr light/12-hr dark
schedule and kept at a relatively constant temperature (20-22 · C). Throughout the
study, rats had free access to food in their home cages.

Apparatus
All experimental sessions were conducted in operant conditioning chambers,
28 cm long x 21 cm wide x 21 cm high (Med Associates, St. Albans, VT). Each
operant chamber contained a single response lever located 7 cm above the floor on
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either the right or left side of the front response panel. An aperture located in the
middle of the response panel allowed access to a dipper that provided 0.1 ml of tap
water. An overhead 28-V house light provided ambient illumination throughout each
experimental session. Each chamber was housed in a sound- and light-attenuating
shell to which masking noise and ventilation were supplied. All experimental events
were controlled and recorded by MED-PC

software and instrumentation (Med

Associates, St. Albans, VT, DOS v2.0) operating on an IBM-compatible personal
computer.
Behavioral Procedure
All rats were water deprived for 24 hr prior to one 1-hr dipper-training
session.

Dipper training sessions entailed delivering water for 4 s under a

variable-time 60-s schedule. Under this schedule, 4-s water deliveries occurred
randomly after an average interval of 60 s, independent of the rats' behavior. All
rats were observed to drink from the dipper by the end of the session. Following the
dipper-training session, rats received lever-press training under an FR 1 schedule
of water delivery. Before the beginning of lever-press training, rats were randomly
assigned a lever position (i.e., left or right). Each rat received FR 1 lever-training
until it made at least 1 00 lever-press responses per session in two consecutive
training sessions.
After the second training session, the FR 1 schedule was changed to an
arithmetically progressing PR 2 schedule of water delivery, which was in effect for
the remainder of the study. Under this schedule, rats earned a 4-s water delivery
upon completion of a response ratio that began at two and was progressively
incremented by two responses after each successive water delivery.

Experimental

sessions ended after 1 hr or when a rat ceased to respond for 5 consecutive minutes
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(i.e.,

the breaking-point

criterion),

whichever occurred first.

The 5-min

breaking-point criterion was only in effect after rats earned their first water
delivery. This was done because previous research suggested that MOMA suppresses
responding early in experimental sessions, with increased responding occurring
later (Byrne et al., 2000).
Following experimental sessions, rats were returned to their home cages and
were given free access to water for 30 min. Sessions were conducted five days per
week, at about the same time each day. After a rat's breaking point was stable for 10
consecutive sessions,

the pharmacological

procedures began.

Stability

was

determined by calculating the mean breaking point for the first 5 sessions (s ub
mean 1), the last 5 sessions (sub-mean 2), and the entire block of 10 sessions
(overall mean).

The difference between the two sub-means was divided by the

overall mean and multiplied by 100, and the data were considered stable if the
resulting

percentage

was

less

than 10

(cf.

Perone,

1991).

After the

pharmacological procedures began, the stability criterion changed such that four
stable sessions were required between injections.

During this time, stability was

assessed by visual inspection of graphed breaking points and was defined as the
absence of increasing or decreasing trends across the previous four sessions.

Pharmacological Procedure
When a rat's responding under the PR schedule was stable, the rat received
four vehicle injections in order to acclimate it to injection procedures.

These

vehicle injections were administered according to a BBBBCC design where B
represents baseline (no injection) sessions and C represents vehicle control (saline
injection) sessions. Upon achieving at least four days of stability after the fourth
vehicle injection, an acute dose-response determination was initiated for that rat.
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During this determination, each rat received four doses of MOMA increased in
quarter-log units (i.e., 1.0, 1.8, 3.2, and 5.6 mg/kg). Drug injections were given
according to a BBBBCD design, where B represents baseline sessions (no injection),
C represents vehicle control sessions (saline injection), and D represents drug
sessions (drug injection).

Each dose was administered twice, and doses were

administered in random order. Doses were chosen on the basis of those that appeared
to be behaviorally active in rats in a prior study from this laboratory (Byrne et al.,
2000).

Water-deprivation Control Procedure
To determine the sensitivity of the PR 2 schedule to a known motivational
variable, the level of water deprivation of each rat was manipulated at the end of the
pharmacological procedures. The logic of this control procedure was that if MOMA
increases the reinforcing effectiveness of water, the drug should have effects similar
to changes in the level of water deprivation (cf. Thompson, 1972a, b). Following the
pharmacological procedures, rats were returned to baseline conditions (i.e., 22.5
hrs of deprivation under the PR 2) for 10 days. At the end of this baseline phase,
rats received continuous free access to water in their home cages (i.e., 0-hr
deprivation), which should have reduced the reinforcing effectiveness of water.
After several PR 2 sessions at 0-hr water deprivation, 4 of 5 rats (Rats 1, 3, 4,
and 5) were returned to a 22.5 deprivation regimen, after which they were tested at
46 hrs of deprivation. Due to time constraints, Rat 2 was tested at 46 hrs of water
deprivation without the intervening baseline sessions. This minor difference in
procedure had no discernible effects on performance.

Drug
MOMA (National Institutes on Drug Abuse, Rockville, MD) was dissolved in
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sterile 0.9% saline solution prepared at an injection volume of 1 ml/kg in sterile
vials and injected intraperitoneally (ip) with a sterile syringe 15 min prior to
behavioral testing. Following injections, rats remained in their home cages until
placed in experimental chambers for the start of test sessions.
Data Analysis

Breaking points and overall response rates were recorded for each session.
The breaking point was defined as the last ratio completed before the session ended.
Response rates were computed by dividing the number of responses by the total
session time. For all rats, dependent measures for all conditions represent the mean
value of experimental sessions under those conditions. For each rat, the means for
breaking points and response rates were based on eight sessions for vehicle, two
sessions for each drug dose, and five sessions for 0-hr deprivation. For each rat,
values for the 46-hr deprivation condition represent data from one session. All data
are expressed as the percent of vehicle control data.
RESULTS
For all rats, sessions usually ended because rats ceased to respond for five
consecutive minutes (i.e., rats met the breaking-point criterion).

Treatment

induced changes in breaking points generally were accompanied by similar changes
in response rates in all rats. The one exception is 1.8 mg/kg MOMA, which had no
effect on the mean breaking point but which decreased the mean response rate.
Figure 1 depicts group mean (± SEM) breaking points for each treatment condition.
Group data are presented because they adequately represent data from individual
rats.

Group mean response rates (standard deviations in parentheses) were 7 .9

(5.0), 154.7 (38.4), 82.6 (45.0), 58.7 (52.1), 8.0 (9.4), and 4.5% (6.1%)
for 0-hr deprivation, 46-hr deprivation, 1.0, 1.8, 3.2, and 5.6 mg/kg MOMA,
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respectively.

Group Data
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Figure 1. Means (± 1 SEM) for breaking points for five rats as a group, for
all experimental conditions. Data are presented in terms of percent vehicle
control. The dashed line indicates control level of responding (i.e., 100%).
Points with error bars that do not overlap are significantly different.
*p < .05; **p < .01
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The effects of treatment conditions on breaking points were assessed with a
one-factor repeated-measures analysis of variance (RM ANOVA) with the degrees of
freedom adjusted according to the Giesser-Greenhouse "conservative" method
(Huitema, 1980).

Results of the RM NO/A (a= .05) revealed significant

differences in breaking points across treatment levels, F(1, 4) = 25.05, p = .0075,
r2 = . 78. To identify significant differences between treatment conditions, pairwise
comparisons using Tukey HSD post-hoc tests were conducted on mean differences in
breaking points between the two deprivation conditions and between each condition
and vehicle control. Table 1 presents the results of these post-hoc tests and their
associated 95% simultaneous confidence intervals; obtained test statistics were
compared to critical values of the Studentized range statistic, q(7, 24) = 4.54 and
5.54, for a= .05 and a= .01, respectively.
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. Table 1
Tukey HSD Post-Hoc Tests and 95% Simultaneous Confidence Intervals
on Mean Differences in Breaking Points
Contrast

Mean Difference

q

Confidence Interval

(134.8, 264.8)

46 hr vs. 0 hr

199.8%

13.95**

46 hr vs. Vehicle

119.2%

8.32**

0 hr vs. Vehicle

-80.6%

-5.63**

(-145.6, -15.6)

(54.2, 184.2)

1.0 mg/kg vs. Vehicle

-0.8%

-0.06

(-64.8, 64.2)

1.8 mg/kg vs. Vehicle

1.4%

0.10

(-63.6, 66.4)

3.2 mg/kg vs. Vehicle

-77.6%

-5.42*

(-142.6, -12.6)

5.6 mg/kg vs. Vehicle

-77.4%

-5.41*

(-142.4, -12.4)

Note: Mean differences in breaking points are presented in terms of percent vehicle
control. These differences represent the effects of the first condition compared to
those of the second condition.
*p < .05. **p < .01

As expected, breaking points after 46 hrs of deprivation were substantially
higher than after O hrs of deprivation.

Compared with vehicle data, 46-hr

deprivation increased, and 0-hr deprivation decreased, mean breaking points. The
effects of 1.0 and 1.8 mg/kg MOMA were inconsistent across rats. For three of five
rats, 1.0 mg/kg had no effect on mean breaking points, but for the other two rats,
this dose slightly increased (Rat 2) and slightly decreased (Rat 4) the mean
breaking points, relative to vehicle.

For Rats 1, 2, and 3, 1.8 mg/kg slightly
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increased mean breaking points above those from vehicle sessions. In contrast, this
dose produced large decreases in mean breaking points for Rats 4 and 5. The two
highest doses, 3.2 and 5.6 mg/kg, decreased mean breaking points in all rats. No
significant increases in breaking points were associated with any dose of MOMA.
Direct observation after MOMA administration revealed that rats remained
active

inside

the

experimental

chamber,

regardless

of dose.

Following

administration of 3.2 and 5.6 mg/kg, all rats exhibited signs of the serotonin
syndrome, including piloerection, head weaving, increased activity, and low body
posture (Green et al., 1995).

Despite the clear disruption in PR performance

following administration of the two highest doses, this disruption was not due to
motoric impairment.
DISCUSSION
One purpose of this study was to evaluate further the behavioral effects of
MOMA, specifically its motivational effects. Contrary to our hypothesis, the present
study found no evidence that MOMA increased the reinforcing effectiveness of water
(i.e., functioned as an EO).

If, as researchers generally assume, breaking points

provide a measure of reinforcing effectiveness (e.g., Hodos, 1961; Hodos & Kalman,
1963; Stafford et al., 1998), the present data suggest that lower doses of MOMA had
no effect on the reinforcing effectiveness of water, while higher doses abolished its
effectiveness. These results are inconsistent with those of other studies (Byrne et
al., 2000; Rezvani et al., 1992), which reported increases in the reinforcing
effectiveness of water following administration of the same doses of MOMA that
abated responding in this study.

This discrepancy in results was not due to the

insensitivity of the PR 2 schedule to fluctuations in the reinforcing effectiveness of
water because changes in the level of water deprivation produced corresponding
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changes in breaking points.
Other studies utilizing

PR schedules have found similar

discrepancies

between the effects of drugs on breaking points and the characteristic motivational
effects of these drugs. For example, Thompson (1972a), Schulze and Paule (1990),
and Thomas (1976) found that low to moderate doses of d-amphetamine generally
increased breaking points for food, even though the drug has well-known anorectic
effects under other conditions (i.e., it reduces the reinforcing effectiveness of

food

and decreases responding for food). Similar results have been obtained with cocaine,
another stimulant drug that typically has anorectic effects (Jones, LeSage, Sundby,
& Poling, 1995).

Moreover, studies examining the behavioral effects of opioid

agonists, which typically increase

food intake, have found that these drugs decrease

breaking points under PR schedules, although subjects may develop a degree of
tolerance to this effect (Jarema, Macomber, LeSage, & Poling, 1999; Macenski,
Schaal, Cleary, & Thompson, 1993; Poling, LeSage, Roe, & Schaefer, 1996).
The data from the present study, along with the findings of previous studies,
call into the question the notion that PR schedules provide a direct indication of how
drugs affect the reinforcing effectiveness of other stimuli . As Jones et al. (1995)
noted, "it should not be automatically assumed that drug-induced changes in PR
breaking points provide an uncontaminated index of the relative effectiveness of the
scheduled reinforcer"

(p. 530).

Schedule-controlled behavior is complexly

determined, and drugs may affect such behavior through a variety of behavioral
mechanisms (McKearney & Barrett, 1978; Poling, Byrne, & Morgan, 2000). For
example, MOMA may increase the relative reinforcing effectiveness of motor
activity, thereby abating behavior maintained by other reinforcers.

This seems

possible given: (a) the drug's widespread use at dance clubs and rave parties, where
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users may dance for extended periods of time, to the exclusion of other, possibly
reinforcing, activities (Green et al., 1995; McDowell & Kleber, 1994; Schwartz &
Miller, 1997); and (b) the increase in the reinforcing effectiveness of activity
produced by other drugs with stimulant properties (e.g., Northrup et al., 1997).
Regardless of MDMA's specific behavioral mechanism of action, converging data from
several studies confirm the need for caution when interpreting the effects of drugs on
responding maintained by PR schedules.
Although we failed to find clear evidence for MDMA's motivational effects, the
present study has value for two reasons.

First;

this study provides more

information regarding the behavioral effects of an increasingly abused club drug,
MOMA. Second, this study examined the EO function of a drug. To our knowledge,
only one other study has explicitly investigated a drug EO (i.e., methylphenidate,
Northrup et al., 1997). Because drugs can function as motivational variables and
drug effects can be modulated by them, such variables deserve increased attention by
behavioral pharmacologists (Snycerski, Laraway, & Poling, 2000). The MO concept
may be of value in guiding such research.

Failure to investigate motivational

variables' effects on behavior "leaves a gap in our understanding of operant
functional relations" (Michael,

1993b, p. 191), preventing us from making

complete and accurate behavioral assessments (Sundberg, 1993).

Behavior

analysts' application of Michael's general approach to motivation has proven useful
in both theory and practice (see, for example, Agnew, 1998; Hall & Sundberg,
1987; Iwata, Smith, & Michael, 2001; McGill, 1999; Laraway et al., 2000; Olson,
Laraway, & Austin, in press; Wilder & Carr, 1998). Given these successes, and the
importance of other operant concepts for understanding drugs' behavioral effects
(Branch, 1991; Byrne & Poling, 2000; Falk, 1996; Johanson, 1978), behavioral
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pharmacologists' adoption of the MO concept will likely improve our behavioral
analyses of drug action.

Appendix A
Protocol Clearance From the Institutional
Animal Care and Use Committee
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